UK TEL: +44 (0) 1234 780020 | USA TEL: +1 888 381 6870
PLACING PEOPLE AND PURPOSE BEFORE PROFIT
The world's first social enterprise, full suite point of care diagnostics developer.
NEWSROOM
Learn about Global Access Diagnostics' news and how we are shaping the world of rapid diagnostics.
INCREASING ACCESS TO DIAGNOSTICS
Global Access Diagnostics (GADx) is a leading developer of lateral flow and rapid diagnostic technologies, products and services, offering a full suite of services from concept to validation to manufacturing at flexible volumes.
Bringing skills together for real impact, we work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.
GADx was formed by the acquisition of two companies, Mologic and Global Access Diagnostics, by a consortium of social impact investors called Global Access Health. As part of this transition, GADx became a social enterprise, dedicating its profits and mission to improving the health and wellbeing of underserved populations around the world.
HISTORY
Mologic was founded in 2003 by Paul Davis and Mark Davis. Paul Davis has deep knowledge of lateral flow technology as the only remaining practicing scientist from the original technology development team (Davis, May and Prior - 1989), that led to the creation of UniPath and the Clearblue brand for home pregnancy testing. Paul’s knowledge of rapid diagnostics and its commercial application is unsurpassed. During his 30+ year tenure with Unilever, Paul innovated across the fields of professional healthcare, consumer healthcare and agriculture, as witnessed by his extensive patent filing history.
In 2009, Mologic was acquired by Alere and set-up as a dedicated R&D unit with a broad scope but with a priority focus on respiratory disease. In 2014, after an Alere leadership and strategy change, Mologic was divested but was brought back to independence through an investor buy-in and management buy-back. The technology, personnel, facilities, capability, intellectual property and a deep product pipeline, stayed with Mologic.
In the years since 2014, Mologic developed an increasingly broad global health portfolio in partnership with the Gates Foundation, FIND and many others. Global Access Health's acquisition was designed to protect the assets and capacity at Mologic so they can prioritize addressing global health challenges with a new and unique business model.
